Cargando…
The anti-cancer properties of heparin and its derivatives: a review and prospect
Heparin, including unfractionated heparin (UFH), low-molecular-weight heparin (LMWH) and heparin derivatives, are commonly used in venous thromboembolism treatment and reportedly have beneficial effects on cancer survival. Heparin can affect the proliferation, adhesion, angiogenesis, migration and i...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513850/ https://www.ncbi.nlm.nih.gov/pubmed/32538273 http://dx.doi.org/10.1080/19336918.2020.1767489 |
_version_ | 1783586463996182528 |
---|---|
author | Ma, Sai-Nan Mao, Zhi-Xiang Wu, Yang Liang, Ming-Xing Wang, Dan-Dan Chen, Xiu Chang, Ping-an Zhang, Wei Tang, Jin-Hai |
author_facet | Ma, Sai-Nan Mao, Zhi-Xiang Wu, Yang Liang, Ming-Xing Wang, Dan-Dan Chen, Xiu Chang, Ping-an Zhang, Wei Tang, Jin-Hai |
author_sort | Ma, Sai-Nan |
collection | PubMed |
description | Heparin, including unfractionated heparin (UFH), low-molecular-weight heparin (LMWH) and heparin derivatives, are commonly used in venous thromboembolism treatment and reportedly have beneficial effects on cancer survival. Heparin can affect the proliferation, adhesion, angiogenesis, migration and invasion of cancer cells via multiple mechanisms. The main mechanisms involve inhibition of heparanase, P-/L-selectin, angiogenesis, and interference with the CXCL12-CXCR4 axis. Here we summarize the current experimental evidence regarding the anti-cancer role of heparin and its derivatives, and conclude that there is evidence to support heparin’s role in inhibiting cancer progression, making it a promising anti-cancer agent. |
format | Online Article Text |
id | pubmed-7513850 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-75138502020-10-01 The anti-cancer properties of heparin and its derivatives: a review and prospect Ma, Sai-Nan Mao, Zhi-Xiang Wu, Yang Liang, Ming-Xing Wang, Dan-Dan Chen, Xiu Chang, Ping-an Zhang, Wei Tang, Jin-Hai Cell Adh Migr Review Heparin, including unfractionated heparin (UFH), low-molecular-weight heparin (LMWH) and heparin derivatives, are commonly used in venous thromboembolism treatment and reportedly have beneficial effects on cancer survival. Heparin can affect the proliferation, adhesion, angiogenesis, migration and invasion of cancer cells via multiple mechanisms. The main mechanisms involve inhibition of heparanase, P-/L-selectin, angiogenesis, and interference with the CXCL12-CXCR4 axis. Here we summarize the current experimental evidence regarding the anti-cancer role of heparin and its derivatives, and conclude that there is evidence to support heparin’s role in inhibiting cancer progression, making it a promising anti-cancer agent. Taylor & Francis 2020-06-14 /pmc/articles/PMC7513850/ /pubmed/32538273 http://dx.doi.org/10.1080/19336918.2020.1767489 Text en © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Ma, Sai-Nan Mao, Zhi-Xiang Wu, Yang Liang, Ming-Xing Wang, Dan-Dan Chen, Xiu Chang, Ping-an Zhang, Wei Tang, Jin-Hai The anti-cancer properties of heparin and its derivatives: a review and prospect |
title | The anti-cancer properties of heparin and its derivatives: a review and prospect |
title_full | The anti-cancer properties of heparin and its derivatives: a review and prospect |
title_fullStr | The anti-cancer properties of heparin and its derivatives: a review and prospect |
title_full_unstemmed | The anti-cancer properties of heparin and its derivatives: a review and prospect |
title_short | The anti-cancer properties of heparin and its derivatives: a review and prospect |
title_sort | anti-cancer properties of heparin and its derivatives: a review and prospect |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513850/ https://www.ncbi.nlm.nih.gov/pubmed/32538273 http://dx.doi.org/10.1080/19336918.2020.1767489 |
work_keys_str_mv | AT masainan theanticancerpropertiesofheparinanditsderivativesareviewandprospect AT maozhixiang theanticancerpropertiesofheparinanditsderivativesareviewandprospect AT wuyang theanticancerpropertiesofheparinanditsderivativesareviewandprospect AT liangmingxing theanticancerpropertiesofheparinanditsderivativesareviewandprospect AT wangdandan theanticancerpropertiesofheparinanditsderivativesareviewandprospect AT chenxiu theanticancerpropertiesofheparinanditsderivativesareviewandprospect AT changpingan theanticancerpropertiesofheparinanditsderivativesareviewandprospect AT zhangwei theanticancerpropertiesofheparinanditsderivativesareviewandprospect AT tangjinhai theanticancerpropertiesofheparinanditsderivativesareviewandprospect AT masainan anticancerpropertiesofheparinanditsderivativesareviewandprospect AT maozhixiang anticancerpropertiesofheparinanditsderivativesareviewandprospect AT wuyang anticancerpropertiesofheparinanditsderivativesareviewandprospect AT liangmingxing anticancerpropertiesofheparinanditsderivativesareviewandprospect AT wangdandan anticancerpropertiesofheparinanditsderivativesareviewandprospect AT chenxiu anticancerpropertiesofheparinanditsderivativesareviewandprospect AT changpingan anticancerpropertiesofheparinanditsderivativesareviewandprospect AT zhangwei anticancerpropertiesofheparinanditsderivativesareviewandprospect AT tangjinhai anticancerpropertiesofheparinanditsderivativesareviewandprospect |